New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 16, 2014
09:08 EDTUNHUnitedHealth cites near-term pressures in ACA, Medicare cuts
The near-term pressures are expected to cost over $1.50 per share in 2014. The company has set a target of having more than $65B in value based contracts with care providers by 2018. It says it will closely study the development of individual public exchanges in 2014 and be "selective" in its approaches for 2015. Initial Medicare growth is within the company's estimates and continue to expect commercial group risk membership to be stable in 2014 with commercial individual insured membership declining over the course of the year. Optum expects strong top and bottom line growth in 2014 with a range of $45B-$46B in revenue. Optum's earnings are expected to be strong in 2H14 due to growth investments early in the year. Expects cash flow from operations in range of $7.8B-$8.2B in 2014 and expect to return $4B to shareholders through repurchase and dividend. Comments taken from Q4 earnings conference call.
News For UNH From The Last 14 Days
Check below for free stories on UNH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
12:53 EDTUNHOn The Fly: Midday Wrap
Subscribe for More Information
10:56 EDTUNHUnitedHealth backs FY14 EPS, revenue guidance
UnitedHealth earlier backed its FY14 EPS view of $5.40-$5.60, consensus $5.59, and its FY14 revenue view of $128B-$129B, consensus $128.94B.
10:51 EDTUNHHealth insurers slide after UnitedHealth results, cautious comments
Shares of a number of health insurers are falling after the largest company in the sector, UnitedHealth (UNH), reported slightly higher than expected first quarter profit but lower than expected revenue. WHAT'S NEW: UnitedHealth's first quarter earnings per share came in at $1.10, versus the consensus outlook of $1.09. The insurer reported revenue of $31.71B, compared with the consensus outlook of $31.99B. Taxes levied by the Affordable Care Act and weak funding of Medicare Advantage by the government weighed on UnitedHealth's earnings, the company stated. Also pushing down the company's earnings was "a very expensive," new Hepatitis C therapy, UnitedHealth stated on its earnings conference call. Hepatitis C treatments cost UnitedHealth hundreds of millions of dollars in the first quarter, the company stated, though it also noted that demand for the treatments should drop going forward as initial pent-up demand for them starts to decline. The company indicated that it was looking to be reimbursed by states for the money it is spending on hepatitis vaccines for Medicaid patients. Meanwhile, UnitedHealth reiterated its fiscal 2014 EPS guidance of $5.40-$5.60 and its fiscal 2014 revenue guidance of $128B-$129B. PRICE ACTION: In mid-morning trading, UnitedHealth sank 3.7% to $75.31. Other health insurers also declined, with WellPoint (WLP) dropping 4% to $91.89, Aetna (AET) falling 3.3% to $67.54, Humana (HUM) declining 2.25% to $106.35, and Health Net (HNT) sliding 1% to $31.74.
06:02 EDTUNHUnitedHealth:Q1 negatively impacted by ACA taxes, ACA provisions, sequestration
Subscribe for More Information
06:02 EDTUNHUnitedHealth reports Q1 Medical Care Ratio 82.5%
Reports Q1 Optum revenue $11.2B
06:01 EDTUNHUnitedHealth reports Q1 EPS $1.10, consensus $1.09
Subscribe for More Information
April 16, 2014
15:17 EDTUNHNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include General Electric (GE), consensus 32c; Philip Morris (PM), consensus $1.16; Schlumberger (SLB), consensus $1.20; PepsiCo (PEP), consensus 75c; Union Pacific (UNP), consensus $2.37; UnitedHealth (UNH), consensus $1.09; Honeywell (HON), consensus $1.26; Goldman Sachs (GS), consensus $3.44; du Pont (DD), consensus $1.59; Morgan Stanley (MS), consensus 60c; Danaher (DHR), consensus 80c; BlackRock (BLK), consensus $4.14; Blackstone (BX), consensus 55c; Chipotle Mexican Grill (CMG), consensus $2.86; Mattel (MAT), consensus 9c; Snap-on (SNA), consensus $1.54; AutoNation (AN), consensus 74c.
10:08 EDTUNHUnitedHealth retreats after Citi cuts rating on shares
Subscribe for More Information
10:00 EDTUNHOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:27 EDTUNHUnitedHealth April volatility elevated at 48 into Q1 and outlook
UnitedHealth April call option implied volatility is at 48, June is at 22, September is at 21; compared to its 26-week average of 23 according to Track Data, suggesting large near term price movement into the expected release of Q1 results on April 17.
05:39 EDTUNHUnitedHealth downgraded to Neutral from Buy at Citigroup
Subscribe for More Information
April 15, 2014
06:32 EDTUNHPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
April 8, 2014
10:18 EDTUNHCMS says Medicare Advantage reimbursement to rise in 2015
Subscribe for More Information
09:23 EDTUNHLeerink views final rates as favorable for MA plans
Subscribe for More Information
April 7, 2014
19:13 EDTUNHCMS issues 2015 rate announcement for Medicare Advantage and Part D programs
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use